Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.

Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, Cheng P, Huang R, Yang L, Hu J, Hou M, Yao Y, Liu L, Wang Y, Wu D, Shen X, Jin J, Luo J, Zeng Y, Zhou X, Xia R, Jiang Z, Bai Y, Wang L, Niu T, Yang R, Hu Y

Open source

DOI: 10.1016/j.rpth.2025.103205
Published: 2025 Oct
Container: Research and practice in thrombosis and haemostasis
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2025.103205,
  title = {Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.},
  author = {Mei H and Liu X and Li Y and Zhou H and Feng Y and Gao G and Cheng P and Huang R and Yang L and Hu J and Hou M and Yao Y and Liu L and Wang Y and Wu D and Shen X and Jin J and Luo J and Zeng Y and Zhou X and Xia R and Jiang Z and Bai Y and Wang L and Niu T and Yang R and Hu Y},
  year = {2025},
  journal = {Research and practice in thrombosis and haemostasis},
  doi = {10.1016/j.rpth.2025.103205},
  url = {https://doi.org/10.1016/j.rpth.2025.103205}
}

RIS

TY  - JOUR
TI  - Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.
AU  - Mei H
AU  - Liu X
AU  - Li Y
AU  - Zhou H
AU  - Feng Y
AU  - Gao G
AU  - Cheng P
AU  - Huang R
AU  - Yang L
AU  - Hu J
AU  - Hou M
AU  - Yao Y
AU  - Liu L
AU  - Wang Y
AU  - Wu D
AU  - Shen X
AU  - Jin J
AU  - Luo J
AU  - Zeng Y
AU  - Zhou X
AU  - Xia R
AU  - Jiang Z
AU  - Bai Y
AU  - Wang L
AU  - Niu T
AU  - Yang R
AU  - Hu Y
PY  - 2025
JO  - Research and practice in thrombosis and haemostasis
DO  - 10.1016/j.rpth.2025.103205
UR  - https://doi.org/10.1016/j.rpth.2025.103205
ER  -

APA

H, M., X, L., Y, L., H, Z., Y, F., G, G., P, C., R, H., L, Y., J, H., M, H., Y, Y., L, L., Y, W., D, W., X, S., J, J., J, L., Y, Z., X, Z., R, X., Z, J., Y, B., L, W., T, N., R, Y., & Y, H. (2025). Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1016/j.rpth.2025.103205

Source records

pubmed · retrieved 2026-09-26T08:34:29.672Z